Sugammadex and Genaral Anesthesia in Two Pediatric Patients with Joubert Syndrome: Case Report

Creative Commons License

Canpolat D. G. , Yildirim M. D. , DOĞAN S. , DOĞRUEL F., PER H. , CANPOLAT M.

ERCIYES MEDICAL JOURNAL, vol.39, no.1, pp.35-36, 2017 (Journal Indexed in ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.5152/etd.2017.16108
  • Title of Journal : ERCIYES MEDICAL JOURNAL
  • Page Numbers: pp.35-36


Joubert syndrome (JS) is a rare genetic disorder that affects the cerebellum, controlling balance, and coordination, and it usually presents a molar tooth sign on magnetic resonance imaging. It is characterized by ataxia, an abnormal breathing pattern referred to as hyperpnea, sleep apnea, hypotonia, and abnormal eye and tongue movements. Because of sensitivity to respiratory depressant agents, including opiates, nitrous oxide, and neuromuscular blockers, and potential difficult airways, anesthetic management requires attention. Sugammadex binds to rocuronium and is a reverse neuromuscular blocker. In this study, two cases of JS where sugammadex was used for general anesthesia are presented. Sugammadex may be a safe general anesthetic for patients with JS.